Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06626048 · ClinicalTrials.gov registry record · NA

Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study

A NA study of Insomnia Disorder, sponsored by University of California, San Francisco.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06626048 is a NA study of Insomnia Disorder that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 10 participants, below the 474-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06626048, a NA study of Insomnia Disorder, is active but no longer recruiting, sponsored by University of California, San Francisco.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This single-arm feasibility trial will provide digital cognitive behavioral therapy for insomnia (CBT-I) and passive body heating (PBH) sessions using a sauna blanket over a 9-week treatment period to adults aged 18 years or older with insomnia disorder.

Conditions Studied

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy for Insomnia
  • DEVICE Passive Body Heating (PBH)

Study Locations (1)

California

  • University of California San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-02-07
Est. Completion 2026-01-28
Phase NA

What the Registry Record Tells You About NCT06626048

The ClinicalTrials.gov registry entry for NCT06626048 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 474-participant average among 8 other Insomnia Disorder trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Insomnia Disorder appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy for Insomnia is the first listed.

NCT06626048 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06626048 about?

NCT06626048 is a clinical study titled "Optimizing an Integrated Mind and Body Treatment for Insomnia: The SLEEPS Study". This single-arm feasibility trial will provide digital cognitive behavioral therapy for insomnia (CBT-I) and passive body heating (PBH) sessions using a sauna blanket over a 9-week treatment period to adults aged 18 years or older with insomnia disorder.

What is the current status of trial NCT06626048?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-02-07. Estimated completion is 2026-01-28.

What conditions does trial NCT06626048 study?

This clinical trial studies the following conditions: Insomnia Disorder.

What interventions are being tested in trial NCT06626048?

The interventions under investigation include: Cognitive Behavioral Therapy for Insomnia (BEHAVIORAL), Passive Body Heating (PBH) (DEVICE).

Who is sponsoring clinical trial NCT06626048?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06626048 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.